It has been demonstrated that TLR4 signaling may promote NAFLD progression, and NASH is characterized by an increased sensitivity to bacterial LPS, a TLR4 ligand (Szabo et al., 2005). Here, TLR4 is linked to metabolic dysfunction-associated steatohepatitis.